Ladder Bio is a therapeutics company developing SpiroligomerTM ladder-shaped peptide-like molecules—sequence-defined, structurally preorganized molecules designed to be orally available, cell permeable, and engage challenging biological targets with high affinity and selectivity. Ladder Bio’s platform
integrates rational design with modern discovery to create new treatment options for patients where conventional modalities fall short. Ladder Bio is headquartered in Blue Bell, PA, a suburb of Philadelphia.